microdosing glp-1 inflammation What Is GLP-1? Full Guide Low Dose GLP-1 for Inflammation:

But their value depends entirely on cold chain precision

For example, in December 2024, Novo Nordisk bought three Catalent sites for US$11bn in order to boost its injectable drug capacity, and in December 2025, Eli Lilly announced new plans to build a US$6bn manufacturing facility in the US

Patients taking insulin or sulfonylureas alongside retatrutide face an increased risk of hypoglycaemia and require close monitoring

Read the original article Join our commenting forum Join thought-provoking conversations, follow other Independent readers and see their replies Comments

S2CID 25517996

Soon after developing GLP-1s, researchers uncovered a second therapeutic effect that could benefit an even larger patient population: sustainable, clinically meaningful weight loss